← Grant listing · GrantsDue Pro
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
National Institutes of Health · PAR-24-296 · Deadline: December 3, 2026
Opportunity-exact history — these numbers describe this specific funding opportunity (PAR-24-296), from NIH RePORTER.
to 4 distinct organizations. By FY: 2025: 4
range $125k – $151k
Listing summary
This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion FOA PAR-.The purpose of the Fogarty Emerging Global Leader Award is to provide research support and protected time (th…
Eligibility: Others · Categories: Education, Environment, Health · official listing ↗
The full brief adds winner tables, recipient breakdowns, the printable "prepared for your client" version, and CSV export — plus a matched-grants list for your client's profile. Client Packet $79 or Pro subscription →
Sources: NIH RePORTER (opportunity-exact) and USAspending (program-level), labeled per section. GrantsDue computes summaries only; verify anything critical against the originals. Methodology.